BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that it will be presenting at LD Micro’s 14th annual Main Event on Tuesday, October 12, 2021, at 1:30 PM PT/4:30 PM ET at the Luxe Sunset Bel-Air in Los Angeles.
ANAHEIM, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that it will be presenting at LD Micro’s 14th annual Main Event on Tuesday, October 12, 2021, at 1:30 PM PT/4:30 PM ET at the Luxe Sunset Bel-Air in Los Angeles. Lourdes Felix, CEO, CFO and Director of BioCorRx Inc., and Brady Granier, President and Director, CEO of BioCorRx Pharmaceuticals, will present at the conference.
Event: LD Micro Main Event
Date: Tuesday, October 12, 2021
Time: 1:30 PM PT/4:30 PM ET
Register to watch the virtual presentation here.
Summary of LD Micro Main Event (XIV)
The 2021 LD Micro Main Event will be held at the Luxe Sunset Bel-Air in Los Angeles from Tuesday, October 12th to Thursday, October 14th.
The festivities run from 8 AM PT - 5:30 PM PT on the 12th and 13th with a morning session on the 14th.
This three-day investor conference is expected to feature around 150 companies, presenting for 25 minutes each, as well as several influential keynotes in person.
For more info, please contact Dean@ldmicro.com
About LD Micro
LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events on an annual basis, LD’s sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.
About BioCorRx
BioCorRx Inc. (OTCQB: BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. Beat Addiction Recovery is a substance use disorder recovery program that typically includes BioCorRx’s proprietary Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx® Weight Loss Program is also a medication assisted weight loss program that includes access to concierge on-demand wellness specialists: nutritionists, fitness experts and personal support from behavioral experts; please visit www.uncraverx.com for more information on UnCraveRx®. The Company also conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals. For more information on BICX and product pipeline, please visit www.BioCorRx.com.
BioCorRx Inc.
investors@BioCorRx.com
714-462-4880
Investor Relations:
Crescendo Communications, LLC
(212) 671-1020 x304
bicx@crescendo-ir.com
